CREATE MEDIC CO.,LTD.

Contact

About Create Medic

Financial Highlights

Net Sales

714_ext_01_0.png

Net Sales by Sales Format

714_ext_02_0.png

Ordinary Income

714_ext_03_0.png

Net Income

714_ext_04_0.png

Business Results Data (Cons.)

Unit:million yen

 
  FY 2013 FY 2014 FY 2015 FY 2016 FY 2017(Est.)
Net Sales 9,880 9,939 9,650 10,003 10,150

Cost of Sales
(% of Net Sales)

5,502
55.7%
5,684
57.2%
5,438
56.4%
5,499
55.0%
5,262
51.8%

Gross Profit
(% of Net Sales)

4,378
44.3%
4,255
42.8%
4,211
43.6%
4,503
45.0%
4,888
48.2%

SG&A expenses
(% of Net Sales)

3,553
36.0%
3,471
34.9%
3,563
36.9%
3,748
37.5%
4,048
39.9%

Operating Income 
(% of Net Sales)

824
8.3%
784
7.9%
648
6.7%
754
7.5%
840
8.3%

Ordinary Income 
(% of Net Sales)

953
9.6%
1,002
10.1%
654
6.8%
821
8.2%
850
8.4%

Net Income
(% of Net Sales)

533
5.4%
490
4.9%
333
3.5%
516
5.2%
550
5.4%

Net Sales by Sales Format(cons.)

Unit:million yen

  FY 2013 FY 2014 FY 2015 FY 2016 FY 2017(Est.)

Own-brand
(%)

6,755
68.4%
6,438
64.8%
6,441
66.8%
6,263
62.6%
6,377
62.8%
OEM Sales
(%)
1,648
16.7%
1,673
16.8%
1,526
15.8%
1,784
17.8%
1,535
15.1%
Overseas
(%)
1,476
14.9%
1,827
18.4%
1,682
17.4%
1,954
19.6%
2,238
22.1%
Total
(%)
9,880
100.0%
9,939
100.0%
9,650
100.0%
10,003
100.0%
10,150
100.0%

Graph Showing Financial Position

714_ext_07_0.png

Free Cash Flow

714_ext_08_0.png

Financial Position Data(cons.)

Unit:million yen

  
  FY 2013 FY 2014 FY 2015 FY 2016 FY 2017(Est.)

Current Assets

10,375 11,421 10,708 11,433 10,549

Fixed Assets

7,068 6,485 6,482 6,178 6,052

Total Assets
(Gross Assets)

17,443 17,906 17,191 17,611 16,602

Current Liabilities

2,827 3,007 2,718 3,294 2,745

Fixed Liabilities

2,254 2,002 1,329 1,713 1,462

Total Liabilities

5,082 5,009 4,047 5,007 4,207

Shareholders' Equity

12,361 12,897 13,143 12,603 12,394

Equity Ratio

70.9% 72.0% 76.5% 71.6% 74.7%

Cash Flow Data

Unit:million yen

  FY 2013 FY 2014 Fy 2015 FY 2016 FY 2017
(Est.)

Net cash provided by (used in) operating activities

951 1,223 715 1,443 1,018

Net cash provided by (used in) investing activities

△ 613 607 △ 492 △ 270 △ 155

Net cash provided by (used in) financing activities

△ 444 △ 709 △ 584 △ 332 △ 627

Net increase(decrease)in cash and cash equivalents

56 1,186 △ 431 719 235

Cash and cash equivalents at end of year

2,953 4,139 3,708 4,427 4,663

Free Cash Flow

337 1,830 223 1,173 862
  • NOTE 1) Figures are shown on a consolidated basis.
  • NOTE 2) Figures are shown rounded down to the nearest million yen.
  • NOTE 3) Free Cash Flow is represented as the total of CF from operating activities + CF from investment activities.

Investment index

  FY 2013 FY 2014 FY 2015 FY 2016 FY 2017(Est.)
ROE 4.5% 3.9% 2.6% 4.0% 4.4%
EPS(yen) 55.49 50.96 34.64 54.73 59.04
BPS(yen) 1,285.47 1,341.24 1,366.83 1,352.97 1,330.54

Dividend per Share (yen)

35 35 35 35 35

Dividend Payout Ratio(cons.)

63.1% 68.7% 101.0% 64.0% 59.3%

TOP